Khiron Life Sciences Corp.: Medical First: Germany Strengthens Reimbursement of Medical Cannabis

On 16 March 2023, after five years of observational data collection the German Federal Joint Committee (G-BA) decided on the future regulations that will govern the prescription of medical cannabis as

Related Keywords

Peru ,Toronto ,Ontario ,Canada ,Germany ,Brazil ,United States ,Colombia ,United Kingdom ,Switzerland ,America ,German ,Alvaro Torres ,Khiron Europe ,Franziska Katterbach ,Linkedin ,Newsfile Corp ,Khiron Life Sciences Corp ,Europe Communications ,German Federal Joint Committee ,Health Committee ,Pharmadrug Production Gmbh ,Life Sciences ,Federal Joint Committee ,Latin America ,Chief Executive Officer ,Khiron ,Life ,Ciences ,Orp ,Medical ,First ,Trengthens ,Reimbursement ,Cannabis ,